Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Phan Thi, T. T.
Text and Data Mining valid from 2019-01-04
2 February 2018
5 September 2018
4 January 2019
Conflicts of interest
The authors declare no conflicts of interest.
None to declare.